FI78473C - Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 1-fenyloxi-2,3,4,5-tetrahydro-3-bensazepinderivat, och vid foerfarandet anvaendbara mellanprodukter. - Google Patents
Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 1-fenyloxi-2,3,4,5-tetrahydro-3-bensazepinderivat, och vid foerfarandet anvaendbara mellanprodukter. Download PDFInfo
- Publication number
- FI78473C FI78473C FI832092A FI832092A FI78473C FI 78473 C FI78473 C FI 78473C FI 832092 A FI832092 A FI 832092A FI 832092 A FI832092 A FI 832092A FI 78473 C FI78473 C FI 78473C
- Authority
- FI
- Finland
- Prior art keywords
- tetrahydro
- benzazepine
- formula
- alkyl
- compound
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 48
- 238000002360 preparation method Methods 0.000 title claims description 7
- YPSCVOIRZZGNDZ-UHFFFAOYSA-N 5-phenoxy-2,3,4,5-tetrahydro-1h-3-benzazepine Chemical class C1NCCC2=CC=CC=C2C1OC1=CC=CC=C1 YPSCVOIRZZGNDZ-UHFFFAOYSA-N 0.000 title description 4
- 239000000543 intermediate Substances 0.000 title description 4
- -1 alkylene amine Chemical class 0.000 claims abstract description 55
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 53
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 34
- 239000001257 hydrogen Substances 0.000 claims abstract description 34
- 150000003839 salts Chemical class 0.000 claims abstract description 33
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 25
- 125000002947 alkylene group Chemical group 0.000 claims abstract description 23
- 150000002431 hydrogen Chemical group 0.000 claims abstract description 21
- 125000003545 alkoxy group Chemical group 0.000 claims abstract description 18
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims abstract description 12
- 229910052736 halogen Inorganic materials 0.000 claims abstract description 11
- 150000002367 halogens Chemical group 0.000 claims abstract description 11
- 239000002253 acid Substances 0.000 claims abstract description 10
- 150000001875 compounds Chemical class 0.000 claims description 84
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims description 9
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 claims description 8
- 125000002088 tosyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])[H])S(*)(=O)=O 0.000 claims description 8
- 150000004820 halides Chemical class 0.000 claims description 7
- 125000000022 2-aminoethyl group Chemical group [H]C([*])([H])C([H])([H])N([H])[H] 0.000 claims description 6
- 239000000935 antidepressant agent Substances 0.000 claims description 5
- 229940005513 antidepressants Drugs 0.000 claims description 5
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical compound [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 claims description 4
- 230000000202 analgesic effect Effects 0.000 claims description 4
- 230000001430 anti-depressive effect Effects 0.000 claims description 4
- 230000003276 anti-hypertensive effect Effects 0.000 claims description 4
- MAIIKQNCBVQRBM-UHFFFAOYSA-N 7,8-dimethoxy-5-phenoxy-2,3,4,5-tetrahydro-1h-3-benzazepine Chemical compound C1=2C=C(OC)C(OC)=CC=2CCNCC1OC1=CC=CC=C1 MAIIKQNCBVQRBM-UHFFFAOYSA-N 0.000 claims description 3
- 229910052783 alkali metal Inorganic materials 0.000 claims description 3
- 150000001340 alkali metals Chemical class 0.000 claims description 3
- 150000001350 alkyl halides Chemical class 0.000 claims description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 3
- 238000007344 nucleophilic reaction Methods 0.000 claims description 3
- CAOMJAMNASENBC-UHFFFAOYSA-N 7,8-dimethoxy-5-[4-(trifluoromethyl)phenoxy]-2,3,4,5-tetrahydro-1h-3-benzazepine Chemical compound C1=2C=C(OC)C(OC)=CC=2CCNCC1OC1=CC=C(C(F)(F)F)C=C1 CAOMJAMNASENBC-UHFFFAOYSA-N 0.000 claims description 2
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 claims description 2
- 125000002252 acyl group Chemical group 0.000 claims description 2
- 125000003342 alkenyl group Chemical group 0.000 claims description 2
- 229910052796 boron Inorganic materials 0.000 claims description 2
- 229910052740 iodine Inorganic materials 0.000 claims description 2
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 claims description 2
- ZMOPIHQDPJYYKW-UHFFFAOYSA-N 5-(3-chlorophenoxy)-7,8-dimethoxy-2,3,4,5-tetrahydro-1h-3-benzazepine Chemical compound C1=2C=C(OC)C(OC)=CC=2CCNCC1OC1=CC=CC(Cl)=C1 ZMOPIHQDPJYYKW-UHFFFAOYSA-N 0.000 claims 1
- VOIFXRDZAJDFPB-UHFFFAOYSA-N 5-(4-methoxyphenoxy)-2,3,4,5-tetrahydro-1h-3-benzazepine Chemical compound C1=CC(OC)=CC=C1OC1C2=CC=CC=C2CCNC1 VOIFXRDZAJDFPB-UHFFFAOYSA-N 0.000 claims 1
- AOHFDDOIDVKIPT-UHFFFAOYSA-N 7,8-dimethoxy-3-methyl-5-[4-(trifluoromethyl)phenoxy]-1,2,4,5-tetrahydro-3-benzazepine Chemical compound C1=2C=C(OC)C(OC)=CC=2CCN(C)CC1OC1=CC=C(C(F)(F)F)C=C1 AOHFDDOIDVKIPT-UHFFFAOYSA-N 0.000 claims 1
- ZUGSPVVYXXJHCM-UHFFFAOYSA-N 7,8-dimethoxy-3-methyl-5-phenoxy-1,2,4,5-tetrahydro-3-benzazepine Chemical compound C1=2C=C(OC)C(OC)=CC=2CCN(C)CC1OC1=CC=CC=C1 ZUGSPVVYXXJHCM-UHFFFAOYSA-N 0.000 claims 1
- WNBKEEWOYWFAIT-UHFFFAOYSA-N 7,8-dimethoxy-5-(4-methoxyphenoxy)-3-methyl-1,2,4,5-tetrahydro-3-benzazepine Chemical compound C1=CC(OC)=CC=C1OC1C2=CC(OC)=C(OC)C=C2CCN(C)C1 WNBKEEWOYWFAIT-UHFFFAOYSA-N 0.000 claims 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 1
- 239000000243 solution Substances 0.000 description 221
- 239000003921 oil Substances 0.000 description 156
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 145
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 144
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 111
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 99
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 96
- 239000000203 mixture Substances 0.000 description 94
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 78
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 63
- 238000004458 analytical method Methods 0.000 description 60
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 53
- 239000011541 reaction mixture Substances 0.000 description 52
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 51
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 50
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 50
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 48
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 39
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 39
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 36
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 33
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 30
- 239000000463 material Substances 0.000 description 30
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 29
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 29
- 239000000725 suspension Substances 0.000 description 28
- 238000003756 stirring Methods 0.000 description 25
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 20
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 20
- 239000007787 solid Substances 0.000 description 20
- 239000000284 extract Substances 0.000 description 19
- 238000010992 reflux Methods 0.000 description 19
- 229910010082 LiAlH Inorganic materials 0.000 description 18
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 18
- 239000000741 silica gel Substances 0.000 description 18
- 229910002027 silica gel Inorganic materials 0.000 description 18
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical class Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 17
- 239000000460 chlorine Substances 0.000 description 16
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 14
- 150000003891 oxalate salts Chemical class 0.000 description 13
- 229910000104 sodium hydride Inorganic materials 0.000 description 13
- JEDZLBFUGJTJGQ-UHFFFAOYSA-N [Na].COCCO[AlH]OCCOC Chemical compound [Na].COCCO[AlH]OCCOC JEDZLBFUGJTJGQ-UHFFFAOYSA-N 0.000 description 12
- 229920006395 saturated elastomer Polymers 0.000 description 12
- 230000037396 body weight Effects 0.000 description 11
- 239000012419 sodium bis(2-methoxyethoxy)aluminum hydride Substances 0.000 description 11
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 10
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 10
- 239000000047 product Substances 0.000 description 10
- 235000017557 sodium bicarbonate Nutrition 0.000 description 10
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 10
- 239000002904 solvent Substances 0.000 description 10
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 9
- 238000010438 heat treatment Methods 0.000 description 9
- 239000012312 sodium hydride Substances 0.000 description 9
- RXPDDRVCOCIHMI-UHFFFAOYSA-N 3-(4-methylphenyl)sulfonyl-1,2,4,5-tetrahydro-3-benzazepin-5-ol Chemical compound C1=CC(C)=CC=C1S(=O)(=O)N1CC(O)C2=CC=CC=C2CC1 RXPDDRVCOCIHMI-UHFFFAOYSA-N 0.000 description 8
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical class [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 8
- 238000004440 column chromatography Methods 0.000 description 8
- FAMRKDQNMBBFBR-BQYQJAHWSA-N diethyl azodicarboxylate Substances CCOC(=O)\N=N\C(=O)OCC FAMRKDQNMBBFBR-BQYQJAHWSA-N 0.000 description 8
- FAMRKDQNMBBFBR-UHFFFAOYSA-N ethyl n-ethoxycarbonyliminocarbamate Chemical compound CCOC(=O)N=NC(=O)OCC FAMRKDQNMBBFBR-UHFFFAOYSA-N 0.000 description 8
- 239000000706 filtrate Substances 0.000 description 8
- 239000004533 oil dispersion Substances 0.000 description 8
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 7
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 7
- SRCZQMGIVIYBBJ-UHFFFAOYSA-N ethoxyethane;ethyl acetate Chemical compound CCOCC.CCOC(C)=O SRCZQMGIVIYBBJ-UHFFFAOYSA-N 0.000 description 7
- 150000002688 maleic acid derivatives Chemical class 0.000 description 7
- YNLHBGLBJHVNTK-UHFFFAOYSA-N 2,3,4,5-tetrahydro-1h-3-benzazepin-5-ol Chemical compound OC1CNCCC2=CC=CC=C12 YNLHBGLBJHVNTK-UHFFFAOYSA-N 0.000 description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- 239000012259 ether extract Substances 0.000 description 6
- 238000004128 high performance liquid chromatography Methods 0.000 description 6
- 239000012074 organic phase Substances 0.000 description 6
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 5
- FLSBQILUUNXTLC-UHFFFAOYSA-N 5-(3-chlorophenoxy)-2,3,4,5-tetrahydro-1h-3-benzazepine Chemical compound ClC1=CC=CC(OC2C3=CC=CC=C3CCNC2)=C1 FLSBQILUUNXTLC-UHFFFAOYSA-N 0.000 description 5
- JEJAWQBUJIIGHW-UHFFFAOYSA-N 5-[4-(trifluoromethyl)phenoxy]-2,3,4,5-tetrahydro-1h-3-benzazepine Chemical compound C1=CC(C(F)(F)F)=CC=C1OC1C2=CC=CC=C2CCNC1 JEJAWQBUJIIGHW-UHFFFAOYSA-N 0.000 description 5
- RENMDAKOXSCIGH-UHFFFAOYSA-N Chloroacetonitrile Chemical compound ClCC#N RENMDAKOXSCIGH-UHFFFAOYSA-N 0.000 description 5
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 5
- 239000002585 base Substances 0.000 description 5
- 230000036772 blood pressure Effects 0.000 description 5
- UORVGPXVDQYIDP-UHFFFAOYSA-N borane Chemical compound B UORVGPXVDQYIDP-UHFFFAOYSA-N 0.000 description 5
- 239000012267 brine Substances 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- UREBWPXBXRYXRJ-UHFFFAOYSA-N ethyl acetate;methanol Chemical compound OC.CCOC(C)=O UREBWPXBXRYXRJ-UHFFFAOYSA-N 0.000 description 5
- RIFGWPKJUGCATF-UHFFFAOYSA-N ethyl chloroformate Chemical compound CCOC(Cl)=O RIFGWPKJUGCATF-UHFFFAOYSA-N 0.000 description 5
- 239000008098 formaldehyde solution Substances 0.000 description 5
- 235000019253 formic acid Nutrition 0.000 description 5
- 229910052757 nitrogen Inorganic materials 0.000 description 5
- 239000012044 organic layer Substances 0.000 description 5
- 229910000027 potassium carbonate Inorganic materials 0.000 description 5
- 238000001953 recrystallisation Methods 0.000 description 5
- 239000011734 sodium Substances 0.000 description 5
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 5
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 4
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 4
- YKWNUSJLICDQEO-UHFFFAOYSA-N ethoxyethane;propan-2-ol Chemical compound CC(C)O.CCOCC YKWNUSJLICDQEO-UHFFFAOYSA-N 0.000 description 4
- 239000012442 inert solvent Substances 0.000 description 4
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 4
- 235000019341 magnesium sulphate Nutrition 0.000 description 4
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 4
- 239000011976 maleic acid Substances 0.000 description 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 4
- RJCGZNCCVKIBHO-UHFFFAOYSA-N 1-chloro-4-fluorobenzene Chemical compound FC1=CC=C(Cl)C=C1 RJCGZNCCVKIBHO-UHFFFAOYSA-N 0.000 description 3
- UNNNAIWPDLRVRN-UHFFFAOYSA-N 1-fluoro-4-(trifluoromethyl)benzene Chemical compound FC1=CC=C(C(F)(F)F)C=C1 UNNNAIWPDLRVRN-UHFFFAOYSA-N 0.000 description 3
- LUIGKSPQPMWPBD-UHFFFAOYSA-N 2-[5-[4-(trifluoromethyl)phenoxy]-1,2,4,5-tetrahydro-3-benzazepin-3-yl]acetonitrile Chemical compound C1=CC(C(F)(F)F)=CC=C1OC1C2=CC=CC=C2CCN(CC#N)C1 LUIGKSPQPMWPBD-UHFFFAOYSA-N 0.000 description 3
- FMWXHMHXIQZWQP-UHFFFAOYSA-N 2-phenyl-1-[5-[4-(trifluoromethyl)phenoxy]-1,2,4,5-tetrahydro-3-benzazepin-3-yl]ethanone Chemical compound C1=CC(C(F)(F)F)=CC=C1OC1C2=CC=CC=C2CCN(C(=O)CC=2C=CC=CC=2)C1 FMWXHMHXIQZWQP-UHFFFAOYSA-N 0.000 description 3
- OTHVHPXQXPEEEN-UHFFFAOYSA-N 3-methyl-5-(4-methylphenoxy)-1,2,4,5-tetrahydro-3-benzazepine;hydrobromide Chemical compound Br.C1N(C)CCC2=CC=CC=C2C1OC1=CC=C(C)C=C1 OTHVHPXQXPEEEN-UHFFFAOYSA-N 0.000 description 3
- DNXJMKZXHNYVLQ-UHFFFAOYSA-N 5-(3-chlorophenoxy)-3-(2-phenylethyl)-1,2,4,5-tetrahydro-3-benzazepine;oxalic acid Chemical compound OC(=O)C(O)=O.ClC1=CC=CC(OC2C3=CC=CC=C3CCN(CCC=3C=CC=CC=3)C2)=C1 DNXJMKZXHNYVLQ-UHFFFAOYSA-N 0.000 description 3
- LZTGRANIEAXJAB-UHFFFAOYSA-N 5-(3-chlorophenoxy)-7,8-dimethoxy-2,3,4,5-tetrahydro-1h-3-benzazepine;oxalic acid Chemical compound OC(=O)C(O)=O.C1=2C=C(OC)C(OC)=CC=2CCNCC1OC1=CC=CC(Cl)=C1 LZTGRANIEAXJAB-UHFFFAOYSA-N 0.000 description 3
- CELRYVDTFOSENW-UHFFFAOYSA-N 7,8-dimethoxy-3-methyl-5-[4-(trifluoromethyl)phenoxy]-1,2,4,5-tetrahydro-3-benzazepine;hydrochloride Chemical compound Cl.C1=2C=C(OC)C(OC)=CC=2CCN(C)CC1OC1=CC=C(C(F)(F)F)C=C1 CELRYVDTFOSENW-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- HXXNUJBODGEODL-UHFFFAOYSA-N N-methyl-2-[5-[4-(trifluoromethyl)phenoxy]-1,2,4,5-tetrahydro-3-benzazepin-3-yl]ethanamine oxalic acid Chemical compound C(C(=O)O)(=O)O.C(C(=O)O)(=O)O.CNCCN1CCC2=C(C(C1)OC1=CC=C(C=C1)C(F)(F)F)C=CC=C2 HXXNUJBODGEODL-UHFFFAOYSA-N 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- 229910000085 borane Inorganic materials 0.000 description 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 3
- IMORGMGAXWQYDB-UHFFFAOYSA-N ethyl 5-[4-(trifluoromethyl)phenoxy]-1,2,4,5-tetrahydro-3-benzazepine-3-carboxylate Chemical compound C1N(C(=O)OCC)CCC2=CC=CC=C2C1OC1=CC=C(C(F)(F)F)C=C1 IMORGMGAXWQYDB-UHFFFAOYSA-N 0.000 description 3
- SSOFTMBPQFNSRI-UHFFFAOYSA-N ethyl n-[2-[5-[4-(trifluoromethyl)phenoxy]-1,2,4,5-tetrahydro-3-benzazepin-3-yl]ethyl]carbamate Chemical compound C1N(CCNC(=O)OCC)CCC2=CC=CC=C2C1OC1=CC=C(C(F)(F)F)C=C1 SSOFTMBPQFNSRI-UHFFFAOYSA-N 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 239000010410 layer Substances 0.000 description 3
- 235000011181 potassium carbonates Nutrition 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 229910000029 sodium carbonate Inorganic materials 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- MKJIEFSOBYUXJB-HOCLYGCPSA-N (3S,11bS)-9,10-dimethoxy-3-isobutyl-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-a]isoquinolin-2-one Chemical compound C1CN2C[C@H](CC(C)C)C(=O)C[C@H]2C2=C1C=C(OC)C(OC)=C2 MKJIEFSOBYUXJB-HOCLYGCPSA-N 0.000 description 2
- ATHNWODHOWZNEQ-BTJKTKAUSA-N (z)-but-2-enedioic acid;3-ethyl-7,8-dimethoxy-5-phenoxy-1,2,4,5-tetrahydro-3-benzazepine Chemical compound OC(=O)\C=C/C(O)=O.C1N(CC)CCC2=CC(OC)=C(OC)C=C2C1OC1=CC=CC=C1 ATHNWODHOWZNEQ-BTJKTKAUSA-N 0.000 description 2
- YWVGLZQJRXEUTE-BTJKTKAUSA-N (z)-but-2-enedioic acid;5-(4-chlorophenoxy)-7,8-dimethoxy-3-methyl-1,2,4,5-tetrahydro-3-benzazepine Chemical compound OC(=O)\C=C/C(O)=O.C1=2C=C(OC)C(OC)=CC=2CCN(C)CC1OC1=CC=C(Cl)C=C1 YWVGLZQJRXEUTE-BTJKTKAUSA-N 0.000 description 2
- DLPAZJHBHBXCIR-UHFFFAOYSA-N 1-[5-[4-(trifluoromethyl)phenoxy]-1,2,4,5-tetrahydro-3-benzazepin-3-yl]propan-1-one Chemical compound C1N(C(=O)CC)CCC2=CC=CC=C2C1OC1=CC=C(C(F)(F)F)C=C1 DLPAZJHBHBXCIR-UHFFFAOYSA-N 0.000 description 2
- VZHJIJZEOCBKRA-UHFFFAOYSA-N 1-chloro-3-fluorobenzene Chemical compound FC1=CC=CC(Cl)=C1 VZHJIJZEOCBKRA-UHFFFAOYSA-N 0.000 description 2
- GBOWGKOVMBDPJF-UHFFFAOYSA-N 1-fluoro-3-(trifluoromethyl)benzene Chemical compound FC1=CC=CC(C(F)(F)F)=C1 GBOWGKOVMBDPJF-UHFFFAOYSA-N 0.000 description 2
- QDKWLJJOYIFEBS-UHFFFAOYSA-N 1-fluoro-4-$l^{1}-oxidanylbenzene Chemical group [O]C1=CC=C(F)C=C1 QDKWLJJOYIFEBS-UHFFFAOYSA-N 0.000 description 2
- HJXVUJRPTUQIAX-UHFFFAOYSA-N 2-[5-(3-chlorophenoxy)-1,2,4,5-tetrahydro-3-benzazepin-3-yl]ethanamine;oxalic acid Chemical compound OC(=O)C(O)=O.OC(=O)C(O)=O.C1N(CCN)CCC2=CC=CC=C2C1OC1=CC=CC(Cl)=C1 HJXVUJRPTUQIAX-UHFFFAOYSA-N 0.000 description 2
- CPBGRDXXGOTGSC-UHFFFAOYSA-N 2-[7,8-dimethoxy-5-[4-(trifluoromethyl)phenoxy]-1,2,4,5-tetrahydro-3-benzazepin-3-yl]acetonitrile Chemical compound C1=2C=C(OC)C(OC)=CC=2CCN(CC#N)CC1OC1=CC=C(C(F)(F)F)C=C1 CPBGRDXXGOTGSC-UHFFFAOYSA-N 0.000 description 2
- 125000001731 2-cyanoethyl group Chemical group [H]C([H])(*)C([H])([H])C#N 0.000 description 2
- VMZCDNSFRSVYKQ-UHFFFAOYSA-N 2-phenylacetyl chloride Chemical compound ClC(=O)CC1=CC=CC=C1 VMZCDNSFRSVYKQ-UHFFFAOYSA-N 0.000 description 2
- LAYRNTTTYMSALS-UHFFFAOYSA-N 3-(2-phenylethyl)-5-[4-(trifluoromethyl)phenoxy]-1,2,4,5-tetrahydro-3-benzazepine Chemical compound C1=CC(C(F)(F)F)=CC=C1OC1C2=CC=CC=C2CCN(CCC=2C=CC=CC=2)C1 LAYRNTTTYMSALS-UHFFFAOYSA-N 0.000 description 2
- LBEQPUMCFYHPIM-UHFFFAOYSA-N 3-(4-methylphenyl)sulfonyl-1,2,4,5-tetrahydro-3-benzazepine Chemical compound C1=CC(C)=CC=C1S(=O)(=O)N1CCC2=CC=CC=C2CC1 LBEQPUMCFYHPIM-UHFFFAOYSA-N 0.000 description 2
- ZOXUTHALVVFSOO-UHFFFAOYSA-N 3-(4-methylphenyl)sulfonyl-5-[4-(trifluoromethyl)phenoxy]-1,2,4,5-tetrahydro-3-benzazepine Chemical compound C1=CC(C)=CC=C1S(=O)(=O)N1CC(OC=2C=CC(=CC=2)C(F)(F)F)C2=CC=CC=C2CC1 ZOXUTHALVVFSOO-UHFFFAOYSA-N 0.000 description 2
- JPVPKERTPABKLW-UHFFFAOYSA-N 3-(4-methylphenyl)sulfonyl-5-phenoxy-1,2,4,5-tetrahydro-3-benzazepine Chemical compound C1=CC(C)=CC=C1S(=O)(=O)N1CC(OC=2C=CC=CC=2)C2=CC=CC=C2CC1 JPVPKERTPABKLW-UHFFFAOYSA-N 0.000 description 2
- NYYRRBOMNHUCLB-UHFFFAOYSA-N 3-chloro-n,n-dimethylpropan-1-amine Chemical compound CN(C)CCCCl NYYRRBOMNHUCLB-UHFFFAOYSA-N 0.000 description 2
- CHKGRHVKBPQKQZ-UHFFFAOYSA-N 3-methyl-5-[4-(trifluoromethyl)phenoxy]-1,2,4,5-tetrahydro-3-benzazepine;hydrochloride Chemical compound Cl.C1N(C)CCC2=CC=CC=C2C1OC1=CC=C(C(F)(F)F)C=C1 CHKGRHVKBPQKQZ-UHFFFAOYSA-N 0.000 description 2
- YNHJTOGHZXHDOG-UHFFFAOYSA-N 3-methyl-5-phenoxy-1,2,4,5-tetrahydro-3-benzazepine;hydrochloride Chemical compound Cl.C1N(C)CCC2=CC=CC=C2C1OC1=CC=CC=C1 YNHJTOGHZXHDOG-UHFFFAOYSA-N 0.000 description 2
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 description 2
- DSQIFHJPKDUDMQ-UHFFFAOYSA-N 5-(3-chlorophenoxy)-3-(cyclopropylmethyl)-1,2,4,5-tetrahydro-3-benzazepine;oxalic acid Chemical compound OC(=O)C(O)=O.ClC1=CC=CC(OC2C3=CC=CC=C3CCN(CC3CC3)C2)=C1 DSQIFHJPKDUDMQ-UHFFFAOYSA-N 0.000 description 2
- UUXSSYRAFLDINZ-UHFFFAOYSA-N 5-(3-chlorophenoxy)-3-methyl-1,2,4,5-tetrahydro-3-benzazepine Chemical compound C1N(C)CCC2=CC=CC=C2C1OC1=CC=CC(Cl)=C1 UUXSSYRAFLDINZ-UHFFFAOYSA-N 0.000 description 2
- DVOIXRDUSKIDOS-UHFFFAOYSA-N 5-(3-chlorophenoxy)-3-propyl-1,2,4,5-tetrahydro-3-benzazepine Chemical compound C1N(CCC)CCC2=CC=CC=C2C1OC1=CC=CC(Cl)=C1 DVOIXRDUSKIDOS-UHFFFAOYSA-N 0.000 description 2
- ZTYXSJCXMOIHOL-BTJKTKAUSA-N 5-(4-bromophenoxy)-7,8-dimethoxy-2,3,4,5-tetrahydro-1h-3-benzazepine;(z)-but-2-enedioic acid Chemical compound OC(=O)\C=C/C(O)=O.C1=2C=C(OC)C(OC)=CC=2CCNCC1OC1=CC=C(Br)C=C1 ZTYXSJCXMOIHOL-BTJKTKAUSA-N 0.000 description 2
- FSOFMYYSNVSUQP-UHFFFAOYSA-N 5-(4-chlorophenoxy)-3-(4-methylphenyl)sulfonyl-1,2,4,5-tetrahydro-3-benzazepine Chemical compound C1=CC(C)=CC=C1S(=O)(=O)N1CC(OC=2C=CC(Cl)=CC=2)C2=CC=CC=C2CC1 FSOFMYYSNVSUQP-UHFFFAOYSA-N 0.000 description 2
- OYEXZZFAVRFXNZ-UHFFFAOYSA-N 5-(4-methoxyphenoxy)-2,3,4,5-tetrahydro-1h-3-benzazepine;oxalic acid Chemical compound OC(=O)C(O)=O.C1=CC(OC)=CC=C1OC1C2=CC=CC=C2CCNC1 OYEXZZFAVRFXNZ-UHFFFAOYSA-N 0.000 description 2
- SMKOBRGTXKBMEO-UHFFFAOYSA-N 5-(4-methoxyphenoxy)-3-(4-methylphenyl)sulfonyl-1,2,4,5-tetrahydro-3-benzazepine Chemical compound C1=CC(OC)=CC=C1OC1C2=CC=CC=C2CCN(S(=O)(=O)C=2C=CC(C)=CC=2)C1 SMKOBRGTXKBMEO-UHFFFAOYSA-N 0.000 description 2
- LLMQTQFMHREURJ-UHFFFAOYSA-N 5-(4-methoxyphenoxy)-3-methyl-1,2,4,5-tetrahydro-3-benzazepine;hydrobromide Chemical compound Br.C1=CC(OC)=CC=C1OC1C2=CC=CC=C2CCN(C)C1 LLMQTQFMHREURJ-UHFFFAOYSA-N 0.000 description 2
- JPCUJJSQPYABLA-UHFFFAOYSA-N 5-(4-methylphenoxy)-2,3,4,5-tetrahydro-1h-3-benzazepine;oxalic acid Chemical compound OC(=O)C(O)=O.C1=CC(C)=CC=C1OC1C2=CC=CC=C2CCNC1 JPCUJJSQPYABLA-UHFFFAOYSA-N 0.000 description 2
- LTCRKTDPHQBEPC-UHFFFAOYSA-N 5-(4-methylphenoxy)-3-(4-methylphenyl)sulfonyl-1,2,4,5-tetrahydro-3-benzazepine Chemical compound C1=CC(C)=CC=C1OC1C2=CC=CC=C2CCN(S(=O)(=O)C=2C=CC(C)=CC=2)C1 LTCRKTDPHQBEPC-UHFFFAOYSA-N 0.000 description 2
- ILIKDGQVHKOXBB-UHFFFAOYSA-N 5-(4-nitrophenoxy)-2,3,4,5-tetrahydro-1h-3-benzazepine;hydrochloride Chemical compound Cl.C1=CC([N+](=O)[O-])=CC=C1OC1C2=CC=CC=C2CCNC1 ILIKDGQVHKOXBB-UHFFFAOYSA-N 0.000 description 2
- TWBRMUSQXHSYSM-UHFFFAOYSA-N 5-[3-(trifluoromethyl)phenoxy]-2,3,4,5-tetrahydro-1h-3-benzazepine;hydrobromide Chemical compound Br.FC(F)(F)C1=CC=CC(OC2C3=CC=CC=C3CCNC2)=C1 TWBRMUSQXHSYSM-UHFFFAOYSA-N 0.000 description 2
- HPHCTDCUNZGPQY-UHFFFAOYSA-N 5-phenoxy-2,3,4,5-tetrahydro-1h-3-benzazepine;hydrochloride Chemical compound Cl.C1NCCC2=CC=CC=C2C1OC1=CC=CC=C1 HPHCTDCUNZGPQY-UHFFFAOYSA-N 0.000 description 2
- FCSKOFQQCWLGMV-UHFFFAOYSA-N 5-{5-[2-chloro-4-(4,5-dihydro-1,3-oxazol-2-yl)phenoxy]pentyl}-3-methylisoxazole Chemical compound O1N=C(C)C=C1CCCCCOC1=CC=C(C=2OCCN=2)C=C1Cl FCSKOFQQCWLGMV-UHFFFAOYSA-N 0.000 description 2
- JUDHUJJPRAQLDC-UHFFFAOYSA-N 7,8-dimethoxy-3-methyl-5-phenoxy-1,2,4,5-tetrahydro-3-benzazepine;oxalic acid Chemical compound OC(=O)C(O)=O.C1=2C=C(OC)C(OC)=CC=2CCN(C)CC1OC1=CC=CC=C1 JUDHUJJPRAQLDC-UHFFFAOYSA-N 0.000 description 2
- OSGWADYCGIGOQO-UHFFFAOYSA-N 7,8-dimethoxy-5-(4-methoxyphenoxy)-3-methyl-1,2,4,5-tetrahydro-3-benzazepine;hydrochloride Chemical compound Cl.C1=CC(OC)=CC=C1OC1C2=CC(OC)=C(OC)C=C2CCN(C)C1 OSGWADYCGIGOQO-UHFFFAOYSA-N 0.000 description 2
- PUHHDEGJJLFLHA-UHFFFAOYSA-N 7,8-dimethoxy-5-[4-(trifluoromethyl)phenoxy]-2,3,4,5-tetrahydro-1h-3-benzazepine;oxalic acid Chemical compound OC(=O)C(O)=O.C1=2C=C(OC)C(OC)=CC=2CCNCC1OC1=CC=C(C(F)(F)F)C=C1 PUHHDEGJJLFLHA-UHFFFAOYSA-N 0.000 description 2
- DBJFASJJLPLYEW-UHFFFAOYSA-N 7,8-dimethoxy-5-phenoxy-2,3,4,5-tetrahydro-1h-3-benzazepine;oxalic acid Chemical compound OC(=O)C(O)=O.C1=2C=C(OC)C(OC)=CC=2CCNCC1OC1=CC=CC=C1 DBJFASJJLPLYEW-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- YNUYSRGKOICQEU-UHFFFAOYSA-N C(C(=O)O)(=O)O.C(C(=O)O)(=O)O.NCCN1CCC2=C(C(C1)OC1=CC=C(C=C1)C(F)(F)F)C=CC=C2 Chemical compound C(C(=O)O)(=O)O.C(C(=O)O)(=O)O.NCCN1CCC2=C(C(C1)OC1=CC=C(C=C1)C(F)(F)F)C=CC=C2 YNUYSRGKOICQEU-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 206010015995 Eyelid ptosis Diseases 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 2
- 239000012346 acetyl chloride Substances 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- ZVTQWXCKQTUVPY-UHFFFAOYSA-N chloromethylcyclopropane Chemical compound ClCC1CC1 ZVTQWXCKQTUVPY-UHFFFAOYSA-N 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- AAOVKJBEBIDNHE-UHFFFAOYSA-N diazepam Chemical compound N=1CC(=O)N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 AAOVKJBEBIDNHE-UHFFFAOYSA-N 0.000 description 2
- 229960003529 diazepam Drugs 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- ZKQFHRVKCYFVCN-UHFFFAOYSA-N ethoxyethane;hexane Chemical compound CCOCC.CCCCCC ZKQFHRVKCYFVCN-UHFFFAOYSA-N 0.000 description 2
- MDKXBBPLEGPIRI-UHFFFAOYSA-N ethoxyethane;methanol Chemical compound OC.CCOCC MDKXBBPLEGPIRI-UHFFFAOYSA-N 0.000 description 2
- NLFBCYMMUAKCPC-KQQUZDAGSA-N ethyl (e)-3-[3-amino-2-cyano-1-[(e)-3-ethoxy-3-oxoprop-1-enyl]sulfanyl-3-oxoprop-1-enyl]sulfanylprop-2-enoate Chemical compound CCOC(=O)\C=C\SC(=C(C#N)C(N)=O)S\C=C\C(=O)OCC NLFBCYMMUAKCPC-KQQUZDAGSA-N 0.000 description 2
- GFVKLWPPOMFGAK-UHFFFAOYSA-N ethyl 7,8-dimethoxy-5-[4-(trifluoromethyl)phenoxy]-1,2,4,5-tetrahydro-3-benzazepine-3-carboxylate Chemical compound C1N(C(=O)OCC)CCC2=CC(OC)=C(OC)C=C2C1OC1=CC=C(C(F)(F)F)C=C1 GFVKLWPPOMFGAK-UHFFFAOYSA-N 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 229910052987 metal hydride Inorganic materials 0.000 description 2
- 150000004681 metal hydrides Chemical class 0.000 description 2
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 2
- BWTBCVAYIHHYNT-UHFFFAOYSA-J oxalate;silicon(4+) Chemical compound [Si+4].[O-]C(=O)C([O-])=O.[O-]C(=O)C([O-])=O BWTBCVAYIHHYNT-UHFFFAOYSA-J 0.000 description 2
- IWDCLRJOBJJRNH-UHFFFAOYSA-N p-cresol Chemical compound CC1=CC=C(O)C=C1 IWDCLRJOBJJRNH-UHFFFAOYSA-N 0.000 description 2
- NWVVVBRKAWDGAB-UHFFFAOYSA-N p-methoxyphenol Chemical compound COC1=CC=C(O)C=C1 NWVVVBRKAWDGAB-UHFFFAOYSA-N 0.000 description 2
- 230000036407 pain Effects 0.000 description 2
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 2
- 235000015320 potassium carbonate Nutrition 0.000 description 2
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 2
- 201000003004 ptosis Diseases 0.000 description 2
- 150000003385 sodium Chemical class 0.000 description 2
- 239000008174 sterile solution Substances 0.000 description 2
- 239000012258 stirred mixture Substances 0.000 description 2
- 229960005333 tetrabenazine Drugs 0.000 description 2
- 238000001665 trituration Methods 0.000 description 2
- HFVMEOPYDLEHBR-UHFFFAOYSA-N (2-fluorophenyl)-phenylmethanol Chemical compound C=1C=CC=C(F)C=1C(O)C1=CC=CC=C1 HFVMEOPYDLEHBR-UHFFFAOYSA-N 0.000 description 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 description 1
- QDPLFWNTMBOORN-BTJKTKAUSA-N (z)-but-2-enedioic acid;5-(4-chlorophenoxy)-7,8-dimethoxy-2,3,4,5-tetrahydro-1h-3-benzazepine Chemical compound OC(=O)\C=C/C(O)=O.C1=2C=C(OC)C(OC)=CC=2CCNCC1OC1=CC=C(Cl)C=C1 QDPLFWNTMBOORN-BTJKTKAUSA-N 0.000 description 1
- LRFOCBQOZHJDFM-BTJKTKAUSA-N (z)-but-2-enedioic acid;5-(4-fluorophenoxy)-7,8-dimethoxy-2,3,4,5-tetrahydro-1h-3-benzazepine Chemical compound OC(=O)\C=C/C(O)=O.C1=2C=C(OC)C(OC)=CC=2CCNCC1OC1=CC=C(F)C=C1 LRFOCBQOZHJDFM-BTJKTKAUSA-N 0.000 description 1
- KWQBGLQNYFNCSS-BTJKTKAUSA-N (z)-but-2-enedioic acid;5-(4-fluorophenoxy)-7,8-dimethoxy-3-methyl-1,2,4,5-tetrahydro-3-benzazepine Chemical compound OC(=O)\C=C/C(O)=O.C1=2C=C(OC)C(OC)=CC=2CCN(C)CC1OC1=CC=C(F)C=C1 KWQBGLQNYFNCSS-BTJKTKAUSA-N 0.000 description 1
- NTURQZFFJDCTMZ-UHFFFAOYSA-N 1-(2-bromoethyl)-4-nitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(CCBr)C=C1 NTURQZFFJDCTMZ-UHFFFAOYSA-N 0.000 description 1
- QDSFIYBVXMTQST-UHFFFAOYSA-N 1-(7,8-dimethoxy-5-phenoxy-1,2,4,5-tetrahydro-3-benzazepin-3-yl)ethanone Chemical compound C1=2C=C(OC)C(OC)=CC=2CCN(C(C)=O)CC1OC1=CC=CC=C1 QDSFIYBVXMTQST-UHFFFAOYSA-N 0.000 description 1
- UXXLTPGCINZEFM-UHFFFAOYSA-N 1-[4-chloro-1-(4-fluorophenyl)butyl]-4-fluorobenzene Chemical compound C1=CC(F)=CC=C1C(CCCCl)C1=CC=C(F)C=C1 UXXLTPGCINZEFM-UHFFFAOYSA-N 0.000 description 1
- AWNXKZVIZARMME-UHFFFAOYSA-N 1-[[5-[2-[(2-chloropyridin-4-yl)amino]pyrimidin-4-yl]-4-(cyclopropylmethyl)pyrimidin-2-yl]amino]-2-methylpropan-2-ol Chemical compound N=1C(NCC(C)(O)C)=NC=C(C=2N=C(NC=3C=C(Cl)N=CC=3)N=CC=2)C=1CC1CC1 AWNXKZVIZARMME-UHFFFAOYSA-N 0.000 description 1
- CYNYIHKIEHGYOZ-UHFFFAOYSA-N 1-bromopropane Chemical compound CCCBr CYNYIHKIEHGYOZ-UHFFFAOYSA-N 0.000 description 1
- WFQDTOYDVUWQMS-UHFFFAOYSA-N 1-fluoro-4-nitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(F)C=C1 WFQDTOYDVUWQMS-UHFFFAOYSA-N 0.000 description 1
- JAYHJCXMAOCSBZ-UHFFFAOYSA-N 1h-1-benzazepine;oxalic acid Chemical compound OC(=O)C(O)=O.N1C=CC=CC2=CC=CC=C12 JAYHJCXMAOCSBZ-UHFFFAOYSA-N 0.000 description 1
- DWDMTORZAVCBJJ-UHFFFAOYSA-N 2,3,4,5-tetrahydro-1H-3-benzazepine hydrobromide Chemical compound Br.C1CNCCC2=CC=CC=C21 DWDMTORZAVCBJJ-UHFFFAOYSA-N 0.000 description 1
- ZTUGICZMQIRBNP-UHFFFAOYSA-N 2,3,4,5-tetrahydro-1h-3-benzazepin-3-ium;chloride Chemical compound Cl.C1CNCCC2=CC=CC=C21 ZTUGICZMQIRBNP-UHFFFAOYSA-N 0.000 description 1
- MWVMYAWMFTVYED-UHFFFAOYSA-N 2,3,4,5-tetrahydro-1h-3-benzazepine Chemical compound C1CNCCC2=CC=CC=C21 MWVMYAWMFTVYED-UHFFFAOYSA-N 0.000 description 1
- HIXDQWDOVZUNNA-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-hydroxy-7-methoxychromen-4-one Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(OC)C(OC)=C1 HIXDQWDOVZUNNA-UHFFFAOYSA-N 0.000 description 1
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 1
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 1
- NWOGOCKRZHMMGP-UHFFFAOYSA-N 2-[5-(3-chlorophenoxy)-1,2,4,5-tetrahydro-3-benzazepin-3-yl]acetonitrile Chemical compound ClC1=CC=CC(OC2C3=CC=CC=C3CCN(CC#N)C2)=C1 NWOGOCKRZHMMGP-UHFFFAOYSA-N 0.000 description 1
- YKLFBRXLEKRCRF-UHFFFAOYSA-N 2-[5-[3-(trifluoromethyl)phenoxy]-1,2,4,5-tetrahydro-3-benzazepin-3-yl]acetonitrile Chemical compound FC(F)(F)C1=CC=CC(OC2C3=CC=CC=C3CCN(CC#N)C2)=C1 YKLFBRXLEKRCRF-UHFFFAOYSA-N 0.000 description 1
- JHWVRHCUFLRKFZ-UHFFFAOYSA-N 2-[5-[4-(trifluoromethyl)phenoxy]-1,2,4,5-tetrahydro-3-benzazepin-3-yl]ethanamine Chemical compound C1N(CCN)CCC2=CC=CC=C2C1OC1=CC=C(C(F)(F)F)C=C1 JHWVRHCUFLRKFZ-UHFFFAOYSA-N 0.000 description 1
- HMGSJZHTXRYLJW-UHFFFAOYSA-N 2-[7,8-dimethoxy-5-[4-(trifluoromethyl)phenoxy]-1,2,4,5-tetrahydro-3-benzazepin-3-yl]ethanamine oxalic acid Chemical compound OC(=O)C(O)=O.OC(=O)C(O)=O.C1=2C=C(OC)C(OC)=CC=2CCN(CCN)CC1OC1=CC=C(C(F)(F)F)C=C1 HMGSJZHTXRYLJW-UHFFFAOYSA-N 0.000 description 1
- OEZPDHRXGCLGKB-UHFFFAOYSA-N 2-chloropropanamide Chemical compound CC(Cl)C(N)=O OEZPDHRXGCLGKB-UHFFFAOYSA-N 0.000 description 1
- LQLJZSJKRYTKTP-UHFFFAOYSA-N 2-dimethylaminoethyl chloride hydrochloride Chemical compound Cl.CN(C)CCCl LQLJZSJKRYTKTP-UHFFFAOYSA-N 0.000 description 1
- 125000003006 2-dimethylaminoethyl group Chemical group [H]C([H])([H])N(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- VNPNJVWHHHXILZ-UHFFFAOYSA-N 2-methoxyethoxyalumane Chemical compound COCCO[AlH2] VNPNJVWHHHXILZ-UHFFFAOYSA-N 0.000 description 1
- RLQZIECDMISZHS-UHFFFAOYSA-N 2-phenylcyclohexa-2,5-diene-1,4-dione Chemical compound O=C1C=CC(=O)C(C=2C=CC=CC=2)=C1 RLQZIECDMISZHS-UHFFFAOYSA-N 0.000 description 1
- FMBJCYMWQLOHMT-UHFFFAOYSA-N 3-(4-methylphenyl)sulfonyl-5-[3-(trifluoromethyl)phenoxy]-1,2,4,5-tetrahydro-3-benzazepine Chemical compound C1=CC(C)=CC=C1S(=O)(=O)N1CC(OC=2C=C(C=CC=2)C(F)(F)F)C2=CC=CC=C2CC1 FMBJCYMWQLOHMT-UHFFFAOYSA-N 0.000 description 1
- UMFLBCMPKRNKNC-UHFFFAOYSA-N 3-(cyclopropylmethyl)-5-[4-(trifluoromethyl)phenoxy]-1,2,4,5-tetrahydro-3-benzazepine;hydrobromide Chemical compound Br.C1=CC(C(F)(F)F)=CC=C1OC1C2=CC=CC=C2CCN(CC2CC2)C1 UMFLBCMPKRNKNC-UHFFFAOYSA-N 0.000 description 1
- MLZRILNPMOFNID-UHFFFAOYSA-N 3-[5-[4-(trifluoromethyl)phenoxy]-1,2,4,5-tetrahydro-3-benzazepin-3-yl]propanenitrile Chemical compound C1=CC(C(F)(F)F)=CC=C1OC1C2=CC=CC=C2CCN(CCC#N)C1 MLZRILNPMOFNID-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- XLTWLUALPNWSLW-UHFFFAOYSA-N 3-ethyl-7,8-dimethoxy-5-[4-(trifluoromethyl)phenoxy]-1,2,4,5-tetrahydro-3-benzazepine;hydrochloride Chemical compound Cl.C1N(CC)CCC2=CC(OC)=C(OC)C=C2C1OC1=CC=C(C(F)(F)F)C=C1 XLTWLUALPNWSLW-UHFFFAOYSA-N 0.000 description 1
- GAWHPTWIXOPVFT-UHFFFAOYSA-N 3-methyl-5-[3-(trifluoromethyl)phenoxy]-1,2,4,5-tetrahydro-3-benzazepine Chemical compound C1N(C)CCC2=CC=CC=C2C1OC1=CC=CC(C(F)(F)F)=C1 GAWHPTWIXOPVFT-UHFFFAOYSA-N 0.000 description 1
- ADFWSYOVSIPTLB-UHFFFAOYSA-N 3-methyl-5-[4-(trifluoromethyl)phenoxy]-1,2,4,5-tetrahydro-3-benzazepine Chemical compound C1N(C)CCC2=CC=CC=C2C1OC1=CC=C(C(F)(F)F)C=C1 ADFWSYOVSIPTLB-UHFFFAOYSA-N 0.000 description 1
- ZEMSVFNMDBQPDX-UHFFFAOYSA-N 3-propyl-5-[4-(trifluoromethyl)phenoxy]-1,2,4,5-tetrahydro-3-benzazepine;hydrobromide Chemical compound Br.C1N(CCC)CCC2=CC=CC=C2C1OC1=CC=C(C(F)(F)F)C=C1 ZEMSVFNMDBQPDX-UHFFFAOYSA-N 0.000 description 1
- IHJATCRRPOSYQS-UHFFFAOYSA-N 3h-3-benzazepine;hydrochloride Chemical compound Cl.C1=CNC=CC2=CC=CC=C21 IHJATCRRPOSYQS-UHFFFAOYSA-N 0.000 description 1
- WXNZTHHGJRFXKQ-UHFFFAOYSA-N 4-chlorophenol Chemical compound OC1=CC=C(Cl)C=C1 WXNZTHHGJRFXKQ-UHFFFAOYSA-N 0.000 description 1
- RHMPLDJJXGPMEX-UHFFFAOYSA-N 4-fluorophenol Chemical compound OC1=CC=C(F)C=C1 RHMPLDJJXGPMEX-UHFFFAOYSA-N 0.000 description 1
- LKZUYXSDKMVQCV-UHFFFAOYSA-N 5-(3-chlorophenoxy)-2,3,4,5-tetrahydro-1h-3-benzazepine;oxalic acid Chemical compound OC(=O)C(O)=O.ClC1=CC=CC(OC2C3=CC=CC=C3CCNC2)=C1 LKZUYXSDKMVQCV-UHFFFAOYSA-N 0.000 description 1
- OHCXTAABZDRATK-UHFFFAOYSA-N 5-(4-chlorophenoxy)-2,3,4,5-tetrahydro-1h-3-benzazepine;oxalic acid Chemical compound OC(=O)C(O)=O.C1=CC(Cl)=CC=C1OC1C2=CC=CC=C2CCNC1 OHCXTAABZDRATK-UHFFFAOYSA-N 0.000 description 1
- UROGRNBSGRSUIY-UHFFFAOYSA-N 5-(4-chlorophenoxy)-3-methyl-1,2,4,5-tetrahydro-3-benzazepine Chemical compound C1N(C)CCC2=CC=CC=C2C1OC1=CC=C(Cl)C=C1 UROGRNBSGRSUIY-UHFFFAOYSA-N 0.000 description 1
- QEHXTTMFQCIOCQ-UHFFFAOYSA-N 5-(4-chlorophenoxy)-7,8-dimethoxy-2,3,4,5-tetrahydro-1h-3-benzazepine Chemical compound C1=2C=C(OC)C(OC)=CC=2CCNCC1OC1=CC=C(Cl)C=C1 QEHXTTMFQCIOCQ-UHFFFAOYSA-N 0.000 description 1
- GFDSIYHZOIENCY-UHFFFAOYSA-N 5-(4-fluorophenoxy)-7,8-dimethoxy-2,3,4,5-tetrahydro-1h-3-benzazepine Chemical compound C1=2C=C(OC)C(OC)=CC=2CCNCC1OC1=CC=C(F)C=C1 GFDSIYHZOIENCY-UHFFFAOYSA-N 0.000 description 1
- FIKCVHYLBNRTOA-UHFFFAOYSA-N 5-(4-fluorophenoxy)-7,8-dimethoxy-3-(4-methylphenyl)sulfonyl-1,2,4,5-tetrahydro-3-benzazepine Chemical compound C1=2C=C(OC)C(OC)=CC=2CCN(S(=O)(=O)C=2C=CC(C)=CC=2)CC1OC1=CC=C(F)C=C1 FIKCVHYLBNRTOA-UHFFFAOYSA-N 0.000 description 1
- HGDDNIPJFVCPPM-UHFFFAOYSA-N 5-(4-methylphenyl)sulfonyl-3H-3-benzazepine Chemical compound CC1=CC=C(C=C1)S(=O)(=O)C1=CNC=CC2=C1C=CC=C2 HGDDNIPJFVCPPM-UHFFFAOYSA-N 0.000 description 1
- GWYVCOXQQWSHPG-UHFFFAOYSA-N 5-[3-(trifluoromethyl)phenoxy]-2,3,4,5-tetrahydro-1h-3-benzazepine Chemical compound FC(F)(F)C1=CC=CC(OC2C3=CC=CC=C3CCNC2)=C1 GWYVCOXQQWSHPG-UHFFFAOYSA-N 0.000 description 1
- DLBVOUHTERRKRW-UHFFFAOYSA-N 7,8-dimethoxy-2,3,4,5-tetrahydro-1h-3-benzazepin-5-ol Chemical compound C1CNCC(O)C2=C1C=C(OC)C(OC)=C2 DLBVOUHTERRKRW-UHFFFAOYSA-N 0.000 description 1
- IDIYBOXGNAFJBP-UHFFFAOYSA-N 7,8-dimethoxy-3-(4-methylphenyl)sulfonyl-1,2,4,5-tetrahydro-3-benzazepin-5-ol Chemical compound C1C(O)C=2C=C(OC)C(OC)=CC=2CCN1S(=O)(=O)C1=CC=C(C)C=C1 IDIYBOXGNAFJBP-UHFFFAOYSA-N 0.000 description 1
- ZRWVGJZKRRLXOG-UHFFFAOYSA-N 7,8-dimethoxy-3-(4-methylphenyl)sulfonyl-5-phenoxy-1,2,4,5-tetrahydro-3-benzazepine Chemical compound C1=2C=C(OC)C(OC)=CC=2CCN(S(=O)(=O)C=2C=CC(C)=CC=2)CC1OC1=CC=CC=C1 ZRWVGJZKRRLXOG-UHFFFAOYSA-N 0.000 description 1
- XBJOTFYSRVFFRV-UHFFFAOYSA-N 7,8-dimethoxy-5-(4-methoxyphenoxy)-3-(4-methylphenyl)sulfonyl-1,2,4,5-tetrahydro-3-benzazepine Chemical compound C1=CC(OC)=CC=C1OC1C2=CC(OC)=C(OC)C=C2CCN(S(=O)(=O)C=2C=CC(C)=CC=2)C1 XBJOTFYSRVFFRV-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical class [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- JEGQLESHHLGSIY-UHFFFAOYSA-N C(C=C/C(=O)O)(=O)O.C(C=C/C(=O)O)(=O)O.NCCCN1CCC2=C(C(C1)OC1=CC=C(C=C1)C(F)(F)F)C=CC=C2 Chemical compound C(C=C/C(=O)O)(=O)O.C(C=C/C(=O)O)(=O)O.NCCCN1CCC2=C(C(C1)OC1=CC=C(C=C1)C(F)(F)F)C=CC=C2 JEGQLESHHLGSIY-UHFFFAOYSA-N 0.000 description 1
- DIIUMSCRCBKMLR-UHFFFAOYSA-N C(C=C/C(=O)O)(=O)O.C1CNCCC2=C1C=CC=C2 Chemical compound C(C=C/C(=O)O)(=O)O.C1CNCCC2=C1C=CC=C2 DIIUMSCRCBKMLR-UHFFFAOYSA-N 0.000 description 1
- ACJSVXLBOMNCDQ-VIBDZMCESA-N C(\C=C/C(=O)O)(=O)O.C(\C=C/C(=O)O)(=O)O.NCCCN1CCC2=C(C(C1)OC1=CC=C(C=C1)C(F)(F)F)C=CC=C2.Br Chemical compound C(\C=C/C(=O)O)(=O)O.C(\C=C/C(=O)O)(=O)O.NCCCN1CCC2=C(C(C1)OC1=CC=C(C=C1)C(F)(F)F)C=CC=C2.Br ACJSVXLBOMNCDQ-VIBDZMCESA-N 0.000 description 1
- DTGJGWAESZRLLP-UHFFFAOYSA-N COC1(NCCC2=C(C1OC1=CC=CC=C1)C=CC=C2)OC Chemical compound COC1(NCCC2=C(C1OC1=CC=CC=C1)C=CC=C2)OC DTGJGWAESZRLLP-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- FKLJPTJMIBLJAV-UHFFFAOYSA-N Compound IV Chemical compound O1N=C(C)C=C1CCCCCCCOC1=CC=C(C=2OCCN=2)C=C1 FKLJPTJMIBLJAV-UHFFFAOYSA-N 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- JPTBXVAPBBXFTP-UHFFFAOYSA-N O(C1=CC=CC=C1)C1NCCC2=C(C1)C=CC=C2 Chemical compound O(C1=CC=CC=C1)C1NCCC2=C(C1)C=CC=C2 JPTBXVAPBBXFTP-UHFFFAOYSA-N 0.000 description 1
- FRJIABQFQPHENX-UHFFFAOYSA-N OC(=O)C(O)=O.C1NCCC2=CC=CC=C2C1OC1=CC=CC=C1 Chemical compound OC(=O)C(O)=O.C1NCCC2=CC=CC=C2C1OC1=CC=CC=C1 FRJIABQFQPHENX-UHFFFAOYSA-N 0.000 description 1
- FADBBGSPIYFKLX-BTJKTKAUSA-N OC(=O)\C=C/C(O)=O.C1=CNC=Cc2ccccc21 Chemical compound OC(=O)\C=C/C(O)=O.C1=CNC=Cc2ccccc21 FADBBGSPIYFKLX-BTJKTKAUSA-N 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 238000006959 Williamson synthesis reaction Methods 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- PQLVXDKIJBQVDF-UHFFFAOYSA-N acetic acid;hydrate Chemical compound O.CC(O)=O PQLVXDKIJBQVDF-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- DNEHKUCSURWDGO-UHFFFAOYSA-N aluminum sodium Chemical compound [Na].[Al] DNEHKUCSURWDGO-UHFFFAOYSA-N 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 239000002220 antihypertensive agent Substances 0.000 description 1
- 229940127088 antihypertensive drug Drugs 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- XYOVOXDWRFGKEX-UHFFFAOYSA-N azepine Chemical compound N1C=CC=CC=C1 XYOVOXDWRFGKEX-UHFFFAOYSA-N 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- WPDGFKWDLXLZQM-UHFFFAOYSA-N chloroethane formic acid Chemical compound C(=O)O.C(C)Cl WPDGFKWDLXLZQM-UHFFFAOYSA-N 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 229940125773 compound 10 Drugs 0.000 description 1
- 239000002178 crystalline material Substances 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000005881 detosylation reaction Methods 0.000 description 1
- XLMALTXPSGQGBX-GCJKJVERSA-N dextropropoxyphene Chemical compound C([C@](OC(=O)CC)([C@H](C)CN(C)C)C=1C=CC=CC=1)C1=CC=CC=C1 XLMALTXPSGQGBX-GCJKJVERSA-N 0.000 description 1
- 229960004193 dextropropoxyphene Drugs 0.000 description 1
- 239000002027 dichloromethane extract Substances 0.000 description 1
- WBKFWQBXFREOFH-UHFFFAOYSA-N dichloromethane;ethyl acetate Chemical compound ClCCl.CCOC(C)=O WBKFWQBXFREOFH-UHFFFAOYSA-N 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- BVQZKSIIHOVGPR-UHFFFAOYSA-N ethyl acetate;methanol Chemical compound OC.OC.CCOC(C)=O BVQZKSIIHOVGPR-UHFFFAOYSA-N 0.000 description 1
- NTBUQDLWHOHUDR-UHFFFAOYSA-N ethyl acetate;n-ethylethanamine Chemical compound CCNCC.CCOC(C)=O NTBUQDLWHOHUDR-UHFFFAOYSA-N 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- ACGDKVXYNVEAGU-UHFFFAOYSA-N guanethidine Chemical compound NC(N)=NCCN1CCCCCCC1 ACGDKVXYNVEAGU-UHFFFAOYSA-N 0.000 description 1
- 229960003602 guanethidine Drugs 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 229960004801 imipramine Drugs 0.000 description 1
- BCGWQEUPMDMJNV-UHFFFAOYSA-N imipramine Chemical compound C1CC2=CC=CC=C2N(CCCN(C)C)C2=CC=CC=C21 BCGWQEUPMDMJNV-UHFFFAOYSA-N 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- ZLVXBBHTMQJRSX-VMGNSXQWSA-N jdtic Chemical compound C1([C@]2(C)CCN(C[C@@H]2C)C[C@H](C(C)C)NC(=O)[C@@H]2NCC3=CC(O)=CC=C3C2)=CC=CC(O)=C1 ZLVXBBHTMQJRSX-VMGNSXQWSA-N 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000003328 mesylation reaction Methods 0.000 description 1
- 230000001035 methylating effect Effects 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- JAMNOLUZQIBPRL-UHFFFAOYSA-N n,n-dimethyl-2-[5-[4-(trifluoromethyl)phenoxy]-3-benzazepin-3-yl]ethanamine;dihydrochloride Chemical compound Cl.Cl.C=1N(CCN(C)C)C=CC2=CC=CC=C2C=1OC1=CC=C(C(F)(F)F)C=C1 JAMNOLUZQIBPRL-UHFFFAOYSA-N 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000005441 o-toluyl group Chemical group [H]C1=C([H])C(C(*)=O)=C(C([H])=C1[H])C([H])([H])[H] 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- FHRZAQIISHKQOT-UHFFFAOYSA-N oxalic acid;2,3,4,5-tetrahydro-1h-3-benzazepine Chemical compound OC(=O)C(O)=O.C1CNCCC2=CC=CC=C21 FHRZAQIISHKQOT-UHFFFAOYSA-N 0.000 description 1
- DBZWGBVCLXHHGQ-UHFFFAOYSA-N oxalic acid;5-[4-(trifluoromethyl)phenoxy]-2,3,4,5-tetrahydro-1h-3-benzazepine Chemical compound OC(=O)C(O)=O.C1=CC(C(F)(F)F)=CC=C1OC1C2=CC=CC=C2CCNC1 DBZWGBVCLXHHGQ-UHFFFAOYSA-N 0.000 description 1
- 125000000636 p-nitrophenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)[N+]([O-])=O 0.000 description 1
- RZWZRACFZGVKFM-UHFFFAOYSA-N propanoyl chloride Chemical compound CCC(Cl)=O RZWZRACFZGVKFM-UHFFFAOYSA-N 0.000 description 1
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical group CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 229940125723 sedative agent Drugs 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 238000011699 spontaneously hypertensive rat Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 description 1
- FIQMHBFVRAXMOP-UHFFFAOYSA-N triphenylphosphane oxide Chemical compound C=1C=CC=CC=1P(C=1C=CC=CC=1)(=O)C1=CC=CC=C1 FIQMHBFVRAXMOP-UHFFFAOYSA-N 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US38791682 | 1982-06-14 | ||
| US06/387,916 US4988690A (en) | 1982-06-14 | 1982-06-14 | 1-aryloxy-2,3,4,5-tetrahydro-3-benzazepines and anti-depressant use thereof |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| FI832092A0 FI832092A0 (fi) | 1983-06-10 |
| FI832092L FI832092L (fi) | 1983-12-15 |
| FI78473B FI78473B (fi) | 1989-04-28 |
| FI78473C true FI78473C (fi) | 1989-08-10 |
Family
ID=23531838
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI832092A FI78473C (fi) | 1982-06-14 | 1983-06-10 | Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 1-fenyloxi-2,3,4,5-tetrahydro-3-bensazepinderivat, och vid foerfarandet anvaendbara mellanprodukter. |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US4988690A (OSRAM) |
| EP (1) | EP0096838B1 (OSRAM) |
| JP (1) | JPS595165A (OSRAM) |
| KR (1) | KR900001214B1 (OSRAM) |
| AT (1) | ATE26263T1 (OSRAM) |
| AU (1) | AU570920B2 (OSRAM) |
| CA (1) | CA1214460A (OSRAM) |
| DE (1) | DE3370621D1 (OSRAM) |
| DK (1) | DK270983A (OSRAM) |
| ES (1) | ES8503666A1 (OSRAM) |
| FI (1) | FI78473C (OSRAM) |
| GR (1) | GR78291B (OSRAM) |
| HU (1) | HU190902B (OSRAM) |
| IE (1) | IE55404B1 (OSRAM) |
| IL (1) | IL68964A (OSRAM) |
| PT (1) | PT76864B (OSRAM) |
| ZA (1) | ZA834309B (OSRAM) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5015639A (en) * | 1987-03-27 | 1991-05-14 | Schering Corporation | Substituted benzazepines, their preparation and pharmaceutical compositions containing them |
| ZA882080B (en) * | 1987-03-27 | 1989-04-26 | Schering Corp | Substituted benzazepines,their preparation and pharmaceutical compositions containing them |
| CA1327795C (en) * | 1987-08-14 | 1994-03-15 | Jules Freedman | Antidepressants which are aryloxy inadanamines |
| US5202319A (en) * | 1991-09-23 | 1993-04-13 | Hoechst-Roussel Pharmaceuticals Inc. | Substituted 3-amino-2,3,4,5-tetrahydro-1-aryloxy-3-benzazepines |
| US5639482A (en) * | 1993-11-10 | 1997-06-17 | Crary; Ely J. | Composition for control and prevention of diabetic retinopathy |
| WO2002044144A2 (en) * | 2000-11-30 | 2002-06-06 | Advanced Research And Technology Institute, Inc. | Nucleophilic approach for preparing radiolabeled imaging agents and associated compounds |
| US6953787B2 (en) * | 2002-04-12 | 2005-10-11 | Arena Pharmaceuticals, Inc. | 5HT2C receptor modulators |
| EP2189448B1 (en) | 2003-06-17 | 2014-01-29 | Arena Pharmaceuticals, Inc. | Processes for the Separation of 3-Benzazepine Racemates |
| JP4782003B2 (ja) * | 2003-06-17 | 2011-09-28 | アリーナ ファーマシューティカルズ， インコーポレイテッド | ５ｈｔ２ｃレセプター関連疾患の処置に有用なベンズアゼピン誘導体 |
| US20080009478A1 (en) * | 2003-10-22 | 2008-01-10 | Arena Pharmaceuticals, Inc. | Benzazepine Derivatives and Methods of Prophylaxis or Treatment of 5Ht2c Receptor Associated Diseases |
| WO2005042490A1 (en) * | 2003-10-22 | 2005-05-12 | Arena Pharmaceuticals, Inc. | Benzazepine derivatives and methods of prophylaxis or treatment of 5ht2c receptor associated diseases |
| SI1838677T1 (sl) | 2004-12-21 | 2010-01-29 | Arena Pharm Inc | Kristalne oblike (R)-8-kloro-1-metil-2,3,4,5-tetrahidro-1H-3-benzazepin hidroklorida |
| AU2005322183B2 (en) | 2004-12-23 | 2012-03-29 | Arena Pharmaceuticals, Inc. | 5HT2C receptor modulator compositions and methods of use |
| JP5199997B2 (ja) * | 2006-04-03 | 2013-05-15 | アリーナ ファーマシューティカルズ， インコーポレイテッド | ８−クロロ−１−メチル−２，３，４，５−テトラヒドロ−１ｈ−３−ベンズアゼピンおよびこれに関連する中間体を調製するためのプロセス |
| ES2522587T3 (es) * | 2006-12-05 | 2014-11-17 | Arena Pharmaceuticals, Inc. | Procesos para preparar (R)-8-cloro-1-metil-2,3,4,5-tetrahidro-1H-3-benzacepina e intermedios de la misma |
| WO2008141082A1 (en) | 2007-05-10 | 2008-11-20 | Amr Technology, Inc. | Aryloxy-and heteroaryloxy-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin |
| EP2288585A1 (en) | 2008-03-04 | 2011-03-02 | Arena Pharmaceuticals, Inc. | Processes for the preparation of intermediates related to the 5-ht2c agonist (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine |
| CN102648170A (zh) | 2009-06-18 | 2012-08-22 | 艾尼纳制药公司 | 制备5-ht2c受体激动剂的方法 |
| US9045431B2 (en) | 2010-06-02 | 2015-06-02 | Arena Pharmaceuticals, Inc. | Processes for the preparation of 5-HT2C receptor agonists |
| CN103347523A (zh) | 2010-09-01 | 2013-10-09 | 艾尼纳制药公司 | 向具有肾损伤的个体给药氯卡色林 |
| EP2611782A1 (en) | 2010-09-01 | 2013-07-10 | Arena Pharmaceuticals, Inc. | Salts of lorcaserin with optically active acids |
| KR20130101524A (ko) | 2010-09-01 | 2013-09-13 | 아레나 파마슈티칼스, 인크. | 5-ｈｔ2ｃ 아고니스트의 비-흡습성 염 |
| CN103189053A (zh) | 2010-09-01 | 2013-07-03 | 艾尼纳制药公司 | 用于体重控制的5-ht2c激动剂的调节释放剂型 |
| CA2886875A1 (en) | 2012-10-09 | 2014-04-17 | Arena Pharmaceuticals, Inc. | Method of weight management |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5233687A (en) * | 1975-09-11 | 1977-03-14 | Shionogi & Co Ltd | Process for preparation of 1,5-dihydro-2h-1,4-benzodiazepine-2-on deri vatives |
| JPS5481290A (en) * | 1977-11-17 | 1979-06-28 | Smithkline Corp | Benzazepin compound |
-
1982
- 1982-06-14 US US06/387,916 patent/US4988690A/en not_active Expired - Fee Related
-
1983
- 1983-06-08 DE DE8383105610T patent/DE3370621D1/de not_active Expired
- 1983-06-08 AT AT83105610T patent/ATE26263T1/de not_active IP Right Cessation
- 1983-06-08 EP EP83105610A patent/EP0096838B1/en not_active Expired
- 1983-06-10 FI FI832092A patent/FI78473C/fi not_active IP Right Cessation
- 1983-06-11 KR KR1019830002597A patent/KR900001214B1/ko not_active Expired
- 1983-06-13 CA CA000430280A patent/CA1214460A/en not_active Expired
- 1983-06-13 IL IL68964A patent/IL68964A/xx unknown
- 1983-06-13 ES ES523191A patent/ES8503666A1/es not_active Expired
- 1983-06-13 JP JP58104343A patent/JPS595165A/ja active Granted
- 1983-06-13 IE IE1384/83A patent/IE55404B1/en unknown
- 1983-06-13 ZA ZA834309A patent/ZA834309B/xx unknown
- 1983-06-13 HU HU832096A patent/HU190902B/hu not_active IP Right Cessation
- 1983-06-13 DK DK270983A patent/DK270983A/da not_active Application Discontinuation
- 1983-06-13 GR GR71648A patent/GR78291B/el unknown
- 1983-06-14 PT PT76864A patent/PT76864B/pt unknown
- 1983-06-14 AU AU15764/83A patent/AU570920B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| GR78291B (OSRAM) | 1984-09-26 |
| EP0096838B1 (en) | 1987-04-01 |
| ES523191A0 (es) | 1985-03-01 |
| ES8503666A1 (es) | 1985-03-01 |
| FI832092A0 (fi) | 1983-06-10 |
| FI78473B (fi) | 1989-04-28 |
| PT76864B (en) | 1986-02-27 |
| CA1214460A (en) | 1986-11-25 |
| KR840005103A (ko) | 1984-11-03 |
| IL68964A (en) | 1988-03-31 |
| IE831384L (en) | 1983-12-14 |
| IL68964A0 (en) | 1983-10-31 |
| PT76864A (en) | 1983-07-01 |
| US4988690A (en) | 1991-01-29 |
| DE3370621D1 (en) | 1987-05-07 |
| DK270983D0 (da) | 1983-06-13 |
| IE55404B1 (en) | 1990-09-12 |
| HU190902B (en) | 1986-12-28 |
| KR900001214B1 (ko) | 1990-02-28 |
| ATE26263T1 (de) | 1987-04-15 |
| JPS595165A (ja) | 1984-01-12 |
| DK270983A (da) | 1983-12-15 |
| AU1576483A (en) | 1983-12-22 |
| FI832092L (fi) | 1983-12-15 |
| ZA834309B (en) | 1984-03-28 |
| AU570920B2 (en) | 1988-03-31 |
| EP0096838A1 (en) | 1983-12-28 |
| JPH0365342B2 (OSRAM) | 1991-10-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI78473C (fi) | Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 1-fenyloxi-2,3,4,5-tetrahydro-3-bensazepinderivat, och vid foerfarandet anvaendbara mellanprodukter. | |
| GB2099425A (en) | Benzazepines and benzodiazines | |
| FI95128B (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten difenyylipropyyliamiinijohdannaisten valmistamiseksi | |
| WO2002074746A1 (en) | Benzazepine derivatives | |
| US20030069254A1 (en) | New arylsulfonyl derivatives with 5-HT6 receptor affinity | |
| NZ196086A (en) | 1-phenyl-2-cyclohexene-1-alkylamine derivatives and pharmaceutical compositions | |
| FI83775B (fi) | Foerfarande foer framstaellning av nya terapeutiskt anvaendbara bensazepinderivat. | |
| FR2660657A1 (fr) | Nouveaux derives du 3-aminochromane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. | |
| NL8001981A (nl) | Benzoxepinederivaat en farmaceutische preparaten op basis daarvan. | |
| US4057560A (en) | 1,2,2A,3,4,5 Hexahydrobenz[c,d]indol-1-yl-2-guanidines | |
| US5059688A (en) | 1-aryloxy-2,3,4,5-tetrahydro-3-benzazepine preparation | |
| US4208410A (en) | Dibenzo[d,g][1,3,6]dioxazocine derivatives | |
| HU177798B (en) | Process for producing substituted pyrrolydines | |
| JPH09501954A (ja) | イミダゾ［５，１−ｃ］［１，４］ベンゾキサジン−１−オンのイミダゾリルアルキル誘導体およびそれらの製造法 | |
| FI86301C (fi) | Foerfarande foer framstaellning av farmaceutiskt anvaendbara naftoxaziner. | |
| US4505918A (en) | 4-[2-Pyridinylthio(oxy or amino)methyl]-1H-imidazoles and derivatives | |
| US4010280A (en) | Phenoxyalkylamine derivatives and preparation thereof | |
| FI80452C (fi) | Foerfarande foer framstaellning av nya terapeutiskt anvaendbara triazino/6,1-a/isokinolin-5-ium-2-/1h)-id- derivat och isomerer daerav. | |
| LU86136A1 (fr) | Nouveaux derives de la phenethylaminoalcoyle-6 furo-(3,4-c)-pyridine,leur preparation et compositions therapeutiques a base de ceux-ci | |
| FI80451C (fi) | Foerfarande foer framstaellning av nya terapeutiskt anvaenbara as-triazino/6,1-a/isokinolinium-derivat och isomerer daerav. | |
| US5202319A (en) | Substituted 3-amino-2,3,4,5-tetrahydro-1-aryloxy-3-benzazepines | |
| US4794181A (en) | 1-aryloxy-2,3,4,5-tetrahydro-3-benzazepines | |
| EP0278265B1 (en) | 1- [(4-Morpholinyl) alkyl] -1H-indoles useful as analgesics and preparation thereof | |
| AU600326B2 (en) | New substituted 3-piperidinamines or 3-azepinamines, the preparation thereof and their applications in therapy | |
| FI85140B (fi) | Foerfarande foer framstaellning av nya terapeutiskt anvaendbara n-(1h-indol-4-yl)-bensamidderivat. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM | Patent lapsed |
Owner name: HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED |